Abstract
Objective
To evaluate the association between p53 codon 72 polymorphism (R72P) and the risk of colorectal liver metastases.
Methods
The p53 R72P genotype was identified by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 78 consecutive colorectal cancer patients with liver metastases and 214 age-and sex-matched cases with nonmetastatic colorectal cancer.
Results
The R allele of the p53 R72P polymorphism was more frequently found in metastatic cases than in nonmetastatic cases (P=0.075). Carriers of the 72R allele had a 2.25-fold (95% CI (confidence interval)= 1.05∼4.83) increased risk of liver metastases. On the stratification analysis, 72R-carrying genotype conferred a 3.46-fold (95% CI=1.02∼11.72) and a 1.05-fold (95% CI=0.36∼3.08) increased risk of liver metastases for p53 overexpression-positive and negative colorectal cancers, respectively.
Conclusion
These results demonstrate for the first time that the 72R allele of the p53 polymorphism has an increased risk for liver metastases in colorectal cancers positive for p53 overexpression.
This is a preview of subscription content, log in via an institution to check access.
References
Adachi, Y., Inomata, M., Kakisako, K., Sato, K., Shiraishi, N., Kitano, S., 1999. Histopathologic characteristics of colorectal cancer with liver metastasis. Dis. Colon. Rectum, 42(8):1053–1056. [doi:10.1007/BF02236702]
Anzola, M., Cuevas, N., Lopez-Martinez, M., Saiz, A., Burgos, J.J., de Pancorbo, M.M., 2003. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma. Cancer Lett., 193(2): 199–205. [doi:10.1016/S0304-3835(03)00046-6]
Bergamaschi, D., Gasco, M., Hiller, L., Sullivan, A., Syed, N., Trigiante, G., Yulug, I., Merlano, M., Numico, G., Comino, A., et al., 2003. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell, 3(4):387–402. [doi:10.1016/S1535-6108(03)00079-5]
Bosman, F.T., 1995. Prognostic value of pathological characteristics of colorectal cancer. Eur. J. Cancer, 31A(7–8): 1216–1221. [doi:10.1016/0959-8049(95)00153-A]
Brooks, L.A., Tidy, J.A., Gusterson, B., Hiller, L., O’Nions, J., Gasco, M., Marin, M.C., Farrell, P.J., Kaelin, W.G.Jr., Crook, T., 2000. Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus. Cancer Res., 60(24):6875–6877.
Burke, D., Allen-Mersh, T.G., 1996. Colorectal liver metastases. Postgrad. Med. J., 72(850):464–469.
Coggi, G., Bosari, S., Roncalli, M., Graziani, D., Bossi, P., Viale, G., Buffa, R., Ferrero, S., Piazza, M., Blandamura, S., et al., 1997. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer, 79(3):425–432. [doi:10.1002/(SICI)1097-0142(19970201)79:3〈425::AID-CNCR1〉3.0.CO;2-H]
Dameron, K.M., Volpert, O.V., Tainsky, M.A., Bouck, N., 1994. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265(5178):1582–1584. [doi:10.1126/science.7521539]
de Jong, K.P., Gouw, A.S., Peeters, P.M., Bulthuis, M., Menkema, L., Porte, R.J., Slooff, M.J., van Goor, H., van den Berg, A., 2005. p53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression. Clin. Cancer Res., 11(11): 4067–4073. [doi:10.1158/1078-0432.CCR-04-2389]
Dumont, P., Leu, J.I., Della Pietra, A.C.3rd, George, D.L., Murphy, M., 2003. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet., 33(3):357–365. [doi:10.1038/ng1093]
Furihata, M., Takeuchi, T., Matsumoto, M., Kurabayashi, A., Ohtsuki, Y., Terao, N., Kuwahara, M., Shuin, T., 2002. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract. Clin. Cancer Res., 8(5):1192–1195.
Ghadjar, P., Coupland, S.E., Na, I.K., Noutsias, M., Letsch, A., Stroux, A., Bauer, S., Buhr, H.J., Thiel, E., Scheibenbogen, C., et al., 2006. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J. Clin. Oncol., 24(12):1910–1916. [doi:10.1200/JCO.2005.04.1822]
Herynk, M.H., Zhang, J., Parikh, N.U., Gallick, G.E., 2007. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. J. Exp. Ther. Oncol., 6(3):205–217.
Hsieh, L.L., Huang, T.H., Chen, I.H., Liao, C.T., Wang, H.M., Lai, C.H., Liou, S.H., Chang, J.T., Cheng, A.J., 2005. p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan. Br. J. Cancer, 92(1):30–35. [doi:10.1038/sj.bjc.6602271]
Kang, S.M., Maeda, K., Onoda, N., Chung, Y.S., Nakata, B., Nishiguchi, Y., Sowa, M., 1997. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int. J. Cancer, 74(5):502–507. [doi:10.1002/(SICI)1097-0215(19971021)74:5〈502::AID-I JC4〉3.0.CO;2-7]
Kastrinakis, W.V., Ramchurren, N., Rieger, K.M., Hess, D.T., Loda, M., Steele, G., Summerhayes, I.C., 1995. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene, 11(4):647–652.
Kawaguchi, H., Ohno, S., Araki, K., Miyazaki, M., Saeki, H., Watanabe, M., Tanaka, S., Sugimachi, K., 2000. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res., 60(11):2753–2755.
Kieser, A., Weich, H.A., Brandner, G., Marme, D., Kolch, W., 1994. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9(3):963–969.
Kimura, O., Sugamura, K., Kijima, T., Makino, M., Shirai, H., Tatebe, S., Ito, H., Kaibara, N., 1996. Flow cytometric examination of p53 protein in primary tumors and metastases to the liver and lymph nodes of colorectal cancer. Dis. Colon. Rectum, 39(12):1428–1433. [doi:10.1007/BF02054534]
Kuramochi, H., Hayashi, K., Uchida, K., Miyakura, S., Shimizu, D., Vallbohmer, D., Park, S., Danenberg, K.D., Takasaki, K., Danenberg, P.V., 2006. Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer. Clin. Cancer Res., 12(1):29–33. [doi:10.1158/1078-0432.CCR-05-1275]
Langerod, A., Bukholm, I.R., Bregard, A., Lonning, P.E., Andersen, T.I., Rognum, T.O., Meling, G.I., Lothe, R.A., Borresen-Dale, A.L., 2002. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Cancer Epidemiol. Biomarkers Prev., 11(12):1684–1688.
Lanham, S., Campbell, I., Watt, P., Gornall, R., 1998. p53 polymorphism and risk of cervical cancer. Lancet, 352(9140):1631. [doi:10.1016/S0140-6736(05)61083-5]
Lee, J.M., Shun, C.T., Wu, M.T., Chen, Y.Y., Yang, S.Y., Hung, H.I., Chen, J.S., Hsu, H.H., Huang, P.M., Kuo, S.W., et al., 2006. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. Mutat. Res., 594(1–2):181–188.
Liang, J.T., Huang, K.C., Jeng, Y.M., Lee, P.H., Lai, H.S., Hsu, H.C., 2004. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer. Br. J. Surg., 91(3):355–361. [doi:10.1002/bjs. 4447]
Lin, H.M., Chatterjee, A., Lin, Y.H., Anjomshoaa, A., Fukuzawa, R., McCall, J.L., Reeve, A.E., 2007. Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncol. Rep., 17(6):1541–1549.
Manfredi, S., Lepage, C., Hatem, C., Coatmeur, O., Faivre, J., Bouvier, A.M., 2006. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg., 244(2):254–259. [doi:10.1097/01.sla.0000217629.94941.cf]
Marin, M.C., Jost, C.A., Brooks, L.A., Irwin, M.S., O’Nions, J., Tidy, J.A., James, N., McGregor, J.M., Harwood, C.A., Yulug, I.G., et al., 2000. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet., 25(1):47–54. [doi:10.1038/75586]
Ogawa, M., Ikeuchi, K., Watanabe, M., Etoh, K., Kobayashi, T., Takao, Y., Anazawa, S., Yamazaki, Y., 2005. Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. Hepatogastroenterology, 52(63):875–880.
Papadakis, E.D., Soulitzis, N., Spandidos, D.A., 2002. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br. J. Cancer, 87(9):1013–1018. [doi:10.1038/sj.bjc.6600595]
Perez, L.O., Abba, M.C., Dulout, F.N., Golijow, C.D., 2006. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J. Gastroenterol., 12(9):1426–1429.
Schneider-Stock, R., Mawrin, C., Motsch, C., Boltze, C., Peters, B., Hartig, R., Buhtz, P., Giers, A., Rohrbeck, A., Freigang, B., et al., 2004a. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am. J. Pathol., 164(4): 1233–1241.
Schneider-Stock, R., Boltze, C., Peters, B., Szibor, R., Landt, O., Meyer, F., Roessner, A., 2004b. Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia, 6(5):529–535. [doi:10.1593/neo.04178]
Shinji, S., Naito, Z., Ishiwata, S., Ishiwata, T., Tanaka, N., Furukawa, K., Suzuki, H., Seya, T., Matsuda, A., Katsuta, M., et al., 2006. Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol. Rep., 15(3):539–543.
Tada, M., Furuuchi, K., Kaneda, M., Matsumoto, J., Takahashi, M., Hirai, A., Mitsumoto, Y., Iggo, R.D., Moriuchi, T., 2001. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants. Carcinogenesis, 22(3):515–517. [doi:10.1093/carcin/22.3.515]
Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L., Matlashewski, G., 1999. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell. Biol., 19(2):1092–1100.
Vermeulen, P.B., Roland, L., Mertens, V., van Marck, E., de Bruijn, E.A., van Oosterom, A.T., Dirix, L.Y., 1996. Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc. Res., 51(2):164–174. [doi:10.1006/mvre.1996.0018]
Zhu, Z.Z., Cong, W.M., Liu, S.F., Xian, Z.H., Wu, W.Q., Wu, M.C., Gao, B., Hou, L.F., Zhu, G.S., 2005. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett., 229(1):77–83. [doi:10.1016/j.canlet.2005.04.014]
Author information
Authors and Affiliations
Corresponding author
Additional information
The two authors contributed equally to this work
Project supported by the National Natural Science Foundation of China (No. 30470791) and the Medical Science and Technology Research Foundation for the 11th Five-Year Program of People’s Liberation Army, Nanjing Branch, China (No. 06MA27)
Rights and permissions
About this article
Cite this article
Zhu, Zz., Liu, B., Wang, Az. et al. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression. J. Zhejiang Univ. Sci. B 9, 847–852 (2008). https://doi.org/10.1631/jzus.B0820100
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B0820100